Answers are grounded in this paper and cite their sources.
This nonrandomized controlled trial used a 1-to-1 therapist-to-patient ratio to administer psilocybin to groups of patients with cancer who were diagnosed with major depression disorder to create a scalable, rapidly effective depression treatment.
No takes yet. Share an insight, caveat, or question.
Agrawal et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: